Skip to content
healthcare.dev
Get a free key

VELCADE

NDC 63020-049, bortezomib, injection, powder, lyophilized, for solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
63020-049
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021602
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63020-049 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORTEZOMIB3.5 mg/1

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package
63020-049-01630200049011 VIAL in 1 CARTON (63020-049-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1521d321-e724-4ffc-adad-34bf4f44fac7

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63020-049

Use it

Look up 63020-049 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63020-049 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63020-049. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.